Merrill J C, Beck D J, Kaminski D A, Li A P
Surgical Research Institute, St. Louis University Health Sciences Center, MO 63110, USA.
Toxicology. 1995 May 23;99(3):147-52. doi: 10.1016/0300-483x(95)03009-5.
Polybrominated biphenyl (PBB) is an industrial chemical and environmental contaminant with known incidence of significant human exposure. PBB has been studied in laboratory animals and found to have significant toxicological effects as well as being a potent inducer of hepatic cytochrome P450 mixed function oxidase (MFO) activity. As part of our program to compare the response of laboratory animals and humans to industrial and environmental toxicants, we studied the effect of a major component of commercial PBB mixtures, 2,2',4,4',5,5'-hexabromobiphenyl (HBB), on MFO induction in primary cultures of human and rat hepatocytes. MFO induction was evaluated by measuring the deethylation of 7-ethoxycoumarin by intact hepatocytes. Rat hepatocytes were found to be highly susceptible to HBB induction of 7-ethoxycoumarin O-deethylase (ECOD) activity, with significant induction observed at the lowest concentration tested of 10(-8) M. Human hepatocytes were found to have a higher threshold for HBB induction of ECOD activity than rat hepatocytes. The lowest concentration of HBB required for ECOD induction observed for human hepatocytes was 10- to 1000-fold higher (10(-7), 10(-6), 10(-5) M for the four human samples) than that found in rat hepatocytes. Future mechanistic investigation of this observed difference in sensitivity towards PBB between rat and human hepatocytes may aid the extrapolation of human health risk from toxicological data obtained from laboratory animals.
多溴联苯(PBB)是一种工业化学品和环境污染物,已知有大量人类接触的情况。PBB已在实验动物中进行研究,发现具有显著的毒理学效应,并且是肝细胞色素P450混合功能氧化酶(MFO)活性的强效诱导剂。作为我们比较实验动物和人类对工业及环境毒物反应的项目的一部分,我们研究了商业PBB混合物的主要成分2,2',4,4',5,5'-六溴联苯(HBB)对原代培养的人肝细胞和大鼠肝细胞中MFO诱导的影响。通过测量完整肝细胞对7-乙氧基香豆素的脱乙基作用来评估MFO诱导。发现大鼠肝细胞对HBB诱导7-乙氧基香豆素O-脱乙基酶(ECOD)活性高度敏感,在测试的最低浓度10^(-8) M时就观察到显著诱导。发现人肝细胞对HBB诱导ECOD活性的阈值高于大鼠肝细胞。人肝细胞诱导ECOD活性所需的HBB最低浓度比大鼠肝细胞高10至1000倍(四个人类样本分别为10^(-7)、10^(-6)、10^(-5) M)。未来对大鼠和人肝细胞对PBB敏感性差异的机制研究可能有助于从实验动物获得的毒理学数据推断人类健康风险。